Cite
APA Citation
Ihata, A., Hagiyama, H., Nagaoka, S., Obata, J., Miyachi, K., Yamada, H., Hirohata, S., Koido, N., Yamasaki, M., Miyagi, K., Ohno, S., Kishimoto, D., Takase, K., Hama, M., Yoshimi, R., Ueda, A., Takeno, M., & Ishigatsubo, Y. (n.d.). fRI0104 Cohort study of infectious disease risk management in RA patients receiving tocilizumab at 48 weeks (ACT4U-study48). Annals of the rheumatic diseases, 71, 344–345. http://access.bl.uk/ark:/81055/vdc_100137792121.0x00005a